Financial reports
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
1 Apr 19
10-Q
2018 Q3
Quarterly report
14 Nov 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
10-Q
2018 Q1
Quarterly report
14 May 18
10-K
2017 FY
Annual report
2 Apr 18
10-Q
2017 Q3
Quarterly report
14 Nov 17
10-Q
2017 Q2
Quarterly report
14 Aug 17
Current reports
8-K
Submission of Matters to a Vote of Security Holders
14 Feb 20
8-K
Completion of Acquisition or Disposition of Assets
14 Feb 20
8-K
Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals
18 Sep 19
8-K
Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter
13 Aug 19
8-K
Departure of Directors or Certain Officers
24 Jul 19
8-K
Other Events
22 Jul 19
8-K
Other Events
19 Jun 19
8-K
Other Events
10 Jun 19
8-K
Regulation FD Disclosure
31 May 19
8-K
Submission of Matters to a Vote of Security Holders
30 May 19
Registration and prospectus
15-12G
Securities registration termination
26 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
425
Business combination disclosure
3 Oct 19
425
Business combination disclosure
23 Sep 19
Proxies
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
17 Jan 19
PRE 14A
Preliminary proxy
7 Jan 19
DEF 14A
Definitive proxy
30 Apr 18
DEF 14A
Definitive proxy
28 Apr 17
DEF 14A
Definitive proxy
25 Oct 16
PRE 14A
Preliminary proxy
11 Oct 16
DEF 14C
Information statement
26 Sep 11
PRER14C
Preliminary revised information
16 Sep 11
PRER14C
Preliminary revised information
13 Sep 11
Other
EFFECT
Notice of effectiveness
12 Feb 19
EFFECT
Notice of effectiveness
15 Mar 17
CORRESP
Correspondence with SEC
14 Mar 17
CORRESP
Correspondence with SEC
14 Mar 17
UPLOAD
Letter from SEC
17 Nov 16
CORRESP
Correspondence with SEC
6 Oct 16
UPLOAD
Letter from SEC
30 Sep 16
EFFECT
Notice of effectiveness
25 Aug 16
CORRESP
Correspondence with SEC
25 Aug 16
CORRESP
Correspondence with SEC
24 Aug 16
Ownership